Androgen receptor activity is affected by both nuclear matrix localization and the phosphorylation status of the heterogeneous nuclear ribonucleoprotein K in anti-androgen-treated LNCaP cells

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Barboro, Paola ^a   Borzì, Luana ^a   Repaci, Erica ^a   Ferrari, Nicoletta ^a   Balbi, Cecilia ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; BICALUTAMIDE; CYPROTERONE ACETATE; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN K;

ARTICLE; CELL NUCLEUS; CELL NUCLEUS MATRIX; CELL PROLIFERATION; CELL STRAIN LNCAP; CELL VIABILITY; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOPLASM; DRUG ANTAGONISM; DRUG MECHANISM; DRUG RECEPTOR BINDING; GEL ELECTROPHORESIS; INTRACELLULAR SPACE; MOLECULAR MECHANICS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; RECEPTOR DOWN REGULATION; WESTERN BLOTTING;

ANDROGEN ANTAGONISTS; CELL LINE, TUMOR; CELL PROLIFERATION; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN K; HUMANS; MALE; NUCLEAR MATRIX; PHOSPHORYLATION; PROSTATIC NEOPLASMS; PROTEIN TRANSPORT; RECEPTORS, ANDROGEN;

EID: 84893365879     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0079212     Document Type: Article

References (44)

1. Siegel R, Naishadham D, Jemal A (2013) Cancer statistics, 2013. CA Cancer J Clin 63: 11-30.
2. Heinlein CA, Chang C (2004) Androgen receptor in prostate cancer. Endocr Rev 25: 276-308. (Pubitemid 38501396)
3. Wirth MP, Hakenberg OW, Froehner M (2007) Antiandrogens in the treatment of prostate cancer. Eur Urol. 51: 306-313.
4. Saraon P, Jarvi K, Diamandis EP (2011) Molecular alterations during progression of prostate cancer to androgen independence. Clin Chem 57: 1366-1375.
5. Mukhopadhyay NK, Kim J, Cinar B, Ramachandran A, Hager MH, et al. (2009) Heterogeneous nuclear ribonucleoprotein K is a novel regulator of androgen receptor translation. Cancer Res 69: 2210-2218.
6. Barboro P, Repaci E, Ferrari N, Rubagotti A, Boccardo F, et al. (2011) Androgen receptor and heterogeneous nuclear ribonucleoprotein K colocalize in the nucleoplasm and are modulated by bicalutamide and 4-hydroxy-tamoxifen in prostatic cancer cell lines. Prostate 71: 1466-1479.
7. Barboro P, Rubagotti A, Boccardo F, Carnemolla B, D'Arrigo C, et al. (2005) Nuclear matrix protein expression in prostate cancer: possible prognostic and diagnostic applications. Anticancer Res 25: 3999-4004. (Pubitemid 41665177)
8. Boccardo F, Rubagotti A, Carmignani G, Romagnoli A, Nicolò G, et al. (2003) Nuclear matrix proteins changes in cancerous prostate tissues and their prognostic value in clinically localized prostate cancer. Prostate 55: 259-264. (Pubitemid 36618184)
9. Ciarlo M, Benelli R, Barbieri O, Minghelli S, Barboro P, et al. (2012) Regulation of neuroendocrine differentiation by AKT/hnRNPK/AR/β-catenin signaling in prostate cancer cells. Int J Cancer 131: 582-590.
10. Kim D, Tucker PW (2006) A regulated nucleocytoplasmic shuttle contributes to Bright's function as a transcriptional activator of immunoglobulin genes. Mol Cell Biol 26: 187-201.
11. Barboro P, D'Arrigo C, Diaspro A, Mormino M, Alberti I, et al. (2002) Unraveling the organization of the internal nuclear matrix: RNA-dependent anchoring of NuMA to a lamin scaffold. Exp Cell Res 279: 202-218. (Pubitemid 35217549)
12. Kaufmann SH, Brunet G, Talbot B, Lamarr D, Dumas C et al (1991) Association of Poly(ADP-Ribose) Polymerase with nuclear matrix: the role intermolecular disulfide bond formation, RNA retention, and cell type. Exp Cell Res 192: 524-536.
13. Zeng C, McNeil S, Pockwinse S, Nickerson J, Shopland L, et al. (1998) Intranuclear targeting of AML/CBFalpha regulatory factors to nuclear matrix-associated transcriptional domains. Proc Natl Acad Sci USA 95: 1585-1589. (Pubitemid 28103436)
14. Barboro P, Rubagotti A, Orecchia P, Spina B, Truini M, et al. (2008) Differential proteomic analysis of nuclear matrix in muscle-invasive bladder cancer: potential to improve diagnosis and prognosis. Cell Oncol 30: 13-26. (Pubitemid 351161036)
15. Kimura Y, Nagata K, Suzuki N, Yokoyama R, Yamanaka Y, et al. (2010) Characterization of multiple alternative forms of heterogeneous nuclear ribonucleoprotein K by phosphate-affinity electrophoresis. Proteomics 10: 3884-3895.
16. Steinberg TH, Agnew BJ, Gee KR, Leung WY, Goodman T, et al. (2003) Global quantitative phosphoprotein analysis using Multiplexed Proteomics technology. Proteomics. 3: 1128-1144. (Pubitemid 36929535)
17. Barboro P, Repaci E, D'Arrigo C, Balbi C (2012) The role of nuclear matrix proteins binding to matrix attachment regions (MARs) in prostate cancer cell differentiation. PLoS One 7: e40617.
18. Muller PY, Janovjak H, Miserez AR, Dobbie Z (2002) Processing of gene expression data generated by quantitative real-time RT-PCR. Biotechniques 32: 1372-1374, 1376, 1378-1379.
19. Masiello D, Chen SY, Xu Y, Verhoeven MC, Choi E, et al. (2004) Recruitment of beta-catenin by wild-type or mutant androgen receptors correlates with ligand-stimulated growth of prostate cancer cells. Mol Endocrinol 18: 2388-2401. (Pubitemid 39335975)
20. Hozák P, Sasseville AM, Raymond Y, Cook PR (1995) Lamin proteins form an internal nucleoskeleton as well as a peripheral lamina in human cells. J Cell Sci 108: 635-644.
21. Tyagi RK, Lavrovsky Y, Ahn SC, Song CS, Chatterjee B, et al. (2000) Dynamics of intracellular movement and nucleocytoplasmic recycling of the ligandactivated androgen receptor in living cells. Mol Endocrinol 14: 1162-1174. (Pubitemid 32260478)
22. Marcelli M, Stenoien DL, Szafran AT, Simeoni S, Agoulnik IU, et al. (2006) Quantifying effects of ligands on androgen receptor nuclear translocation, intranuclear dynamics, and solubility. J Cell Biochem 98: 770-788. (Pubitemid 43993395)
23. Jackson DA (2006) The nucleus - An overview. In: Hiscox JA editor. Viruses and the nucleus John Wiley & Sons, West Sussex, UK. 1-24.
24. Bomsztyk K, Denisenko O, Ostrowski J (2004) hnRNP K: one protein multiple processes. Bioessays 26: 629-638. (Pubitemid 38758340)
25. Habelhah H, Shah K, Huang L, Ostareck-Lederer A, Burlingame AL, et al. (2001) ERK phosphorylation drives cytoplasmic accumulation of hnRNP-K and inhibition of mRNA translation. Nat Cell Biol 3: 325-330. (Pubitemid 32201331)
26. Ostrowski J, Kawata Y, Schullery DS, Denisenko ON, Higaki Y, et al. (2001) Insulin alters heterogeneous nuclear ribonucleoprotein K protein binding to DNA and RNA. Proc Natl Acad Sci U S A. 98: 9044-9049. (Pubitemid 32743866)
27. Habelhah H, Shah K, Huang L, Burlingame AL, Shokat KM, et al.(2001) Identification of new JNK substrate using ATP pocket mutant JNK and a corresponding ATP analogue. J Biol Chem 276: 18090-18095.
28. Lin J, Adam R M, Santiestevan E, Freeman MR (1999) The phosphatidylinositol 3′-kinase pathway is a dominant growth factor-activated cell survival pathway in LNCaP human prostate carcinoma cells. Cancer Res 59: 2891-2897. (Pubitemid 29283128)
29. Bertram J, Peacock JW, Fazli L, Mui ALF, Chung SW, et al. (2006) Loss of PTEN is associated with progression to androgen independence. Prostate 66: 895-902. (Pubitemid 43849588)
30. Davies SP, Reddy H, Caivano M, Cohen P (2000) Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351: 95-105.
31. Veldscholte J, Berrevoets CA, Ris-Stalpers C, Kuiper GG, Jenster G, et al. (1992) The androgen receptor in LNCaP cells contains a mutation in the ligand binding domain which affects steroid binding characteristics and response to antiandrogens. J Steroid Biochem Mol Biol. 41: 665-669.
32. Barrack ER (1983) The nuclear matrix of the prostate contains acceptor sites for androgen receptors. Endocrinology 113: 430-432.
33. Brown TR, Migeon CJ (1986) Androgen binding in nuclear matrix of human genital skin fibroblasts from patients with androgen insensitivity syndrome. J Clin Endocrinol Metab. 62: 542-550. (Pubitemid 16138174)
34. Gonor SE, Lakey WH, McBlain WA (1984) Relationship between concentrations of extractable and matrix-bound nuclear androgen receptor and clinical response to endocrine therapy for prostatic adenocarcinoma. J Urol 131: 1196-1201. (Pubitemid 14082448)
35. Zink D, Fischer AH, Nickerson JA (2004) Nuclear structure in cancer cells. Nat Rev Cancer 4: 677-687. (Pubitemid 39215066)
36. Gluch A, Vidakovic M, Bode J (2008) Scaffold/matrix attachment regions (S/MARs): relevance for disease and therapy. Handb Exp Pharmacol 186: 67-103.
37. Buttyan R, Olsson CA, Sheard B, Kallos J (1983) Steroid receptor-nuclear matrix interactions. The role of DNA. J Biol Chem 258: 14366-14370. (Pubitemid 14220287)
38. Barboro P, D'Arrigo C, Mormino M, Coradeghini R, Parodi S, et al. (2003) An intranuclear frame for chromatin compartmentalization and higher-order folding. J Cell Biochem 88: 113-120. (Pubitemid 36015080)
39. Barboro P, D'Arrigo C, Repaci E, Bagnasco L, Orecchia P, et al. (2009) Proteomic analysis of the nuclear matrix in the early stages of rat liver carcinogenesis: identification of differentially expressed and MAR-binding proteins. Exp Cell Res 315: 226-239.
40. Saitoh N, Spahr CS, Patterson SD, Bubulya P, Neuwald AF, et al. (2004) Proteomic analysis of interchromatin granule clusters. Mol Biol Cell 15: 3876-3890. (Pubitemid 38989721)
41. Alberti I, Barboro P, Barbesino M, Sanna P, Pisciotta L, et al. (2000) Changes in the expression of cytokeratins and nuclear matrix proteins are correlated with the level of differentiation in human prostate cancer. J Cell Biochem 79: 471-485.
42. Barboro P, Repaci E, Rubagotti A, Salvi S, Boccardo S, et al (2009) Heterogeneous nuclear ribonucleoprotein K: altered pattern of expression associated with diagnosis and prognosis of prostate cancer. Br J Cancer 100: 1608-1616.
43. Ricci F, Rubagotti A, Zinoli L, Mangerini R, Nuzzo PV, et al. (2012) Prognostic value of nuclear matrix protein expression in localized prostate cancer. J Cancer Res Clin Oncol 138: 1379-1384.
44. Moumen A, Magill C, Dry KL, Jackson SP (2013) ATM-dependent phosphorylation of heterogeneous nuclear ribonucleoprotein K promotes p53 transcriptional activation in response to DNA damage. Cell Cycle 12: 698-704.